Modulation of the renin-angiotensin system and retinopathy

Heart

Volumn 84, Issue SUPP, 2000, Pages

  Chaturvedi, Nish ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RENIN;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL TRIAL; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE SEVERITY; HUMAN; HYPERTENSION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETINOPATHY; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0033851803     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.84.suppl_1.i29     Document Type: Article

References (8)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
2. Volpert OV, Ward WF, Lingen MW, et al. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest 1996;98:671-9.
3. Parving HH, Larsen M, Hommel E, et al Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy. Diabetologia. 1989;32:440-4.
4. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macro vascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998;317:713-20.
5. The EUCLID study group. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 1997;349:1787-92.
6. Sorbi D, Fadly M, Hicks R, et al. Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases. Kidney Int 1993;44:1266-72.
7. Ebihara I, Nakamura T, Shimada N, et al. Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1998;32:544-50.
8. Nielsen S, Dollerup J, Nielsen B, et al. Losartan reduces albuminuria in patients with essential hypertension. An enalapril controlled 3 months study. Nephrol Dial Transplant. 1997;12(suppl 2):19-23.